Vidal, Priscila M.

HRN: 00-55-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2022
CEFTRIAXONE 1G (VIAL)
10/15/2022
10/21/2022
IV
2gm
Q24
AGE
Waiting Final Action 
10/16/2022
METRONIDAZOLE 500MG (TAB)
10/16/2022
10/22/2022
PO
500mg
TID
Entamoeba Coli, AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: